MDSpire - Summary
Feature

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference

Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida.

  • March 26, 2026

  • 3 min

Share

Experts from Roswell Park Comprehensive Cancer Center will present at the 2026 NCCN Annual Conference in Orlando, showcasing advancements in cancer research including SurVaxM immunotherapy for neuroendocrine tumors and various studies on breast cancer, pancreatic cancer, and CAR-T therapy outcomes. Notable speakers include Dr. Reem Dergham, sharing insights on early clinical trial findings, and Dr. Jessica Young, participating in a breast cancer panel. The conference aims to enhance patient-centered care and promote efficient cancer treatment methodologies.

Original Source(s)

Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference

  • March 26, 2026

Related Content

AI As Collaborator in Cancer Research and in Clinical Care

Last October, the Cancer AI Alliance (CAIA) announced the launch of its collaborative artificial intelligence (AI) platform powered by federated learning to train AI models with millions of de-identif...

AI Use in Cancer Diagnosis, Prognosis, and Treatment: Are We There Yet?

The promise of artificial intelligence (AI) technologies to provide highly personalized oncology care for patients and improve outcomes has been decades in the making. In a 1987 editorial in The New E...

Stanford Names Leader for Drug Development and Precision Oncology

Vivek Subbiah, MD, has been appointed as the inaugural associate director for drug development and precision oncology at the Stanford Cancer Institute, with a planned start date in spring 2026. In thi...